Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.


NDAQ:BNTX - Post by User

BioNTech SE
<< Previous
 Bullboard Posts
User Avatar Image
(291)
•••
Post by whytestockson Dec 18, 2024 10:00pm
29 Views
Post# 36369476

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Breaking News: $BNTX 3 No-Brainer Biotech Stocks to Buy With $200 Right Now2024-12-18 05:44:00 ET Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the inherent risks of developing new drugs. However, some biotech stocks offer attractive opportunities for investors that are hard to ignore. And ...BNTX - 3 No-Brainer Biotech Stocks to Buy With $200 Right Now

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities